CSIMarket Company Name, Ticker, Competitors, else..
 
Enlivex Therapeutics Ltd  (NASDAQ: ENLV)
 

Enlivex Therapeutics Ltd's Suppliers Performance

ENLV's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
ENLV Costs vs Sales of Suppliers Growth

• More on ENLV Suppliers






Enlivex Therapeutics Ltd's Comment on Supply Chain


The company sources raw materials from various countries, including Israel, where its primary operating subsidiary, Enlivex Therapeutics R&D Ltd., is based. Enlivex R&D has received approximately $8.0 million in royalty-bearing grants from the Israeli Innovation Authority (IIA) to support its research and development activities. These grants may include conditions related to manufacturing products and transferring technologies outside Israel, with potential penalties for non-compliance. The company incurs expenses in multiple currencies, including the New Israeli Shekel (NIS) and Euro, which may impact earnings due to exchange rate fluctuations.

Enlivex Therapeutics Ltd's Comment on Supply Chain


The company sources raw materials from various countries, including Israel, where its primary operating subsidiary, Enlivex Therapeutics R&D Ltd., is based. Enlivex R&D has received approximately $8.0 million in royalty-bearing grants from the Israeli Innovation Authority (IIA) to support its research and development activities. These grants may include conditions related to manufacturing products and transferring technologies outside Israel, with potential penalties for non-compliance. The company incurs expenses in multiple currencies, including the New Israeli Shekel (NIS) and Euro, which may impact earnings due to exchange rate fluctuations.







ENLV's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Enlivex Therapeutics Ltd 1.93 0.00 1,235.53 34
SUBTOTAL 0.00 0.00 0.00 -


Sources: Enlivex Therapeutics Ltd's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Enlivex Therapeutics Ltd’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.